Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lestaurtinib in Myelofibrosis
NCT00494585Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2007
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lestaurtinib in myelofibrosis (MF), sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2007; status: completed.
02
Drugs
lestaurtinib
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT00494585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00494585.